Evidence map›Paper›PMID 35602545›Full record

ArticlePhysics and imaging in radiation oncology2022

Cone-beam computed tomography-guided online adaptive radiotherapy is feasible for prostate cancer patients.

Lisanne G M Zwart, Francisca Ong, Liselotte A Ten Asbroek, Erik B van Dieren, Siete A Koch, Anand Bhawanie, Elisabeth de Wit, Judith J Dasselaar

Abstract read
In one paragraph

Article in Physics and imaging in radiation oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Review
  2. Article
  3. Biologically adaptive radiation oncology in oligometastatic and oligoprogressive disease: MR- and CBCT-guided adaptation, molecular imaging, dose painting, biomarkers, and AI.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lisanne G M ZwartDepartment of Radiotherapy, Medisch Spectrum Twente, Koningsplein 1, 7512 KZ Enschede, The Netherlands.
Francisca OngDepartment of Radiotherapy, Medisch Spectrum Twente, Koningsplein 1, 7512 KZ Enschede, The Netherlands.
Liselotte A Ten AsbroekDepartment of Radiotherapy, Medisch Spectrum Twente, Koningsplein 1, 7512 KZ Enschede, The Netherlands.
Erik B van DierenDepartment of Radiotherapy, Medisch Spectrum Twente, Koningsplein 1, 7512 KZ Enschede, The Netherlands.
Siete A KochDepartment of Radiotherapy, Medisch Spectrum Twente, Koningsplein 1, 7512 KZ Enschede, The Netherlands.
Anand BhawanieDepartment of Radiotherapy, Medisch Spectrum Twente, Koningsplein 1, 7512 KZ Enschede, The Netherlands.
Elisabeth de WitDepartment of Radiotherapy, Medisch Spectrum Twente, Koningsplein 1, 7512 KZ Enschede, The Netherlands.
Judith J DasselaarDepartment of Radiotherapy, Medisch Spectrum Twente, Koningsplein 1, 7512 KZ Enschede, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and purpose: Studies have shown the potential of cone-beam computed tomography (CBCT)-guided online adaptive radiotherapy (oART) for prostate cancer patients in a simulation environment. The aim of this study was to evaluate the feasibility of the clinical implementation of CBCT-guided oART for prostate cancer patients. Materials and methods: Between February and July 2020, eleven prostate cancer patients were treated with CBCT-guided oART using a fractionation scheme of 20 × 3 Gy to the prostate and 20 × 2.7/3.0 Gy to the seminal vesicles for more advanced stages. The on-couch adaptive workflow consisted of influencer (prostate, seminal vesicles, rectum, bladder) review, target review, scheduled (re-calculated) and adapted (re-optimized) plan generation, an independent QA procedure and treatment delivery. Treatment time, proportion of adapted fractions and reasons for plan adaptation were evaluated. Results: Mean total treatment time (±SD) from CBCT acquisition to end of treatment delivery was 17.5 ± 3.2 min (range: 10.8-28.8 min). In all 220 fractions, the PTV coverage was increased for the adapted plan compared to the scheduled plan. The V60Gy of bladder and rectum were below the constraints (<5% and <3%) for both scheduled and adapted plans in 171 out of 220 fractions and for the adapted plan only in 30 out of 220 fractions. In 19 out of 220 fractions, the V60Gy of the bladder and/or rectum was above the constraint for the adapted plan. Conclusions: The clinical implementation of CBCT-guided oART is feasible for prostate cancer patients. The adaptive workflow is possible within twenty minutes on average with a dedicated team.

Indexed as

CBCT-guided radiotherapyOnline adaptive radiotherapyProstate cancer

Identifiers

PMID35602545
PMCPMC9115122

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.